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Abstract:  Correction of the eye’s monochromatic aberrations using 
adaptive optics (AO) can improve the resolution of in vivo mouse retinal 
images [Biss et al., Opt. Lett. 32(6), 659 (2007) and Alt et al., Proc. SPIE 
7550, 755019 (2010)], but previous attempts have been limited by poor spot 
quality in the Shack-Hartmann wavefront sensor (SHWS). Recent advances 
in mouse eye wavefront sensing using an adjustable focus beacon with an 
annular beam profile have improved the wavefront sensor spot quality 
[Geng et al., Biomed. Opt. Express 2(4), 717 (2011)], and we have 
incorporated them into a fluorescence adaptive optics scanning laser 
ophthalmoscope (AOSLO). The performance of the instrument was tested 
on the living mouse eye, and images of multiple retinal structures, including 
the photoreceptor mosaic, nerve fiber bundles, fine capillaries and 
fluorescently labeled ganglion cells were obtained. The in vivo transverse 
and axial resolutions of the fluorescence channel of the AOSLO were 
estimated from the full width half maximum (FWHM) of the line and point 
spread functions (LSF and PSF), and were found to be better than 0.79 μm ± 
0.03 μm (STD)(45% wider than the diffraction limit) and 10.8 μm ± 0.7 μm 
(STD)(two times the diffraction limit), respectively. The axial positional 
accuracy  was  estimated  to  be  0.36  μm.  This  resolution  and  positional 
accuracy has allowed us to classify many ganglion cell types, such as 
bistratified ganglion cells, in vivo. 
© 2012 Optical Society of America 
OCIS codes: (170.4460) Ophthalmic optics and devices; (110.1080) Active or adaptive optics; 
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1. Introduction 
Mouse models have become increasingly important for understanding the normal and diseased 
eye due to their availability for genetic manipulations not yet common in other mammals [1–
4]. The conventional methods for studying mouse eye models are in vitro physiology and 
histology, which require a large number of animals for statistical analysis and do not allow for 
longitudinal studies in single animals. Non-invasive microscopic imaging of the mouse retina 
would allow tracking of retinal development, disease progression, or the efficacy of therapy in 
single animals over time. This can reduce the number of animals required and the animal-to-
animal variability inherent in studying the dynamics of a process from different animals 
sacrificed at different time points. Recently, there have been a growing number of studies 
focused on in vivo optical imaging of the mouse retina, utilizing fundus cameras, scanning 
laser ophthalmoscopes (SLO), or optical coherence tomography (OCT) [5–14]. However, in 
vivo  imaging resolution is compromised by ocular aberrations in the mouse eye, and the 
classical resolution limit has not been reached [15,16]. 
The fully dilated mouse eye has a NA of 0.49, two times greater than that of the human 
eye. This offers a transverse diffraction-limited resolution 2 times better (0.7 μm vs. 1.4 μm, 
for a wavelength of 550 nm), and an axial resolution limit 4 times better than the human eye 
(6 μm vs. 25 μm). The size of retinal structures is similar in both species, yet the volume of 
the point spread function (PSF) is 16 times smaller. The larger NA also increases light 
collection efficiency by fourfold. 
To take full advantage of the high NA of the mouse eye, its monochromatic aberrations 
can be corrected with AO. For confocal imaging, having an improved PSF not only increases 
image contrast and resolution, but also increases the detected signal. AO has enabled 
diffraction-limited imaging of cellular and sub-cellular structures in living human and primate 
eyes [17–22]. Recent studies have also demonstrated benefits of AO applied to rodent eyes 
[23–25]. 
In vivo imaging of the mouse eye is challenging due to its small pupil size, large average 
refractive error, and a retina that is over 50 times thicker than the human retina as measured in 
diopters, as shown in Table 1. If a deformable mirror is used to section the retina, a much 
larger stroke is needed for the mouse eye than the human eye. 
The small pupil size forces tighter tolerances in designing and aligning an optical 
instrument and the animal. Given the large focusing range required to cover the mouse retina, 
the mouse AOSLO has to perform well over a vergence range 5 times larger than that of the 
human retina (Table 1) [21]. Therefore, the monochromatic aberrations of the AOSLO were 
minimized over a range of vergences spanning the whole thickness of the mouse retina, as 
discussed in the next section. In our system, the wavefront sensing source was focused on  
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Dilated 
pupil size 
(mm) 
f 
(mm) 
Total 
eye 
power 
Average 
refractive 
error 
Average 
retinal 
thickness 
(mm) 
Power 
needed to 
section the 
retina 
P-V Zernike 
defocus needed 
to section the 
retina** 
Human  8.0  16.7  60 D  ~0 to +1 D 
[26,27]
 
0.25  0.7 D  5.5 µm 
Mouse  2.0  1.9  520 D  +7 to +15 D 
[16,28,29] 
−7 to −11 D 
[15] 
0.22  49.5 D  25 µm 
*Mouse eye focal length in air (f), total eye power and average retinal thickness are calculated from average data for 
100 days old C57BL/6 mice [28]. Human eye optics parameters are taken from the Gullstrand-LeGrand Eye Model 
[30]. 
**P-V: peak-to-valley. 
the outer retina (the most reflective layer), and the reflectance and fluorescence imaging 
sources were focused on the retinal layer of interest. Monochromatic aberrations affecting the 
image quality in the planes conjugate to the pupil were also compensated for, in order to 
achieve good AO correction. 
2. Methods 
2.1. The fluorescence AOSLO customized for the mouse eye 
A custom fluorescence AOSLO was built, combining wavefront sensing methodology 
previously developed for the mouse eye and design principles of broadband AOSLOs for the 
human eye [15,21]. A schematic layout of the system is shown in Fig. 1. Note that the actual 
optical system was folded in 3D, and was flattened in Fig. 1 for illustration. 
Three light sources were used for wavefront sensing and imaging after being coupled to 
single mode optical fibers and mounted on translation stages allowing for independent 
focusing. All source focuses could be adjusted by changing the distance between the source 
fibers and their collimating lenses. An 843 nm laser diode (LD) from Qphotonics (Ann Arbor, 
Michigan, USA) was used as the wavefront sensing source. A 789 nm superluminescent diode 
(SLD) with 11.5 nm bandwidth (InPhenix, Livermore, California, USA) was used as the 
reflectance imaging light source. An air-cooled Argon laser (CVI Melles Griot, Albuquerque, 
New Mexico, USA) provided multiple spectral lines between 457 and 514 nm for 
fluorescence imaging. 
The optical path consists of five, 4-f, afocal telescope pairs that relay image the eye’s pupil 
onto several system pupil planes. All mirrors are commercially available with protective silver 
coating. The achromatic lens is a 400 mm effective focal length, 100 mm diameter achromat 
with broadband anti-reflection coating for 400 to 900 nm (Ross Optical, El Paso, Texas, 
USA). Note that the flatter side of the achromat faces the eye to minimize spherical 
aberrations for all angles required to form the imaging raster. The system pupil planes include 
the deformable mirror for wavefront correction, two scanners for raster scanning of the retina, 
and the SHWS lenslet array. The deformable mirror used was a large stroke hi-speed DM97 
from ALPAO S.A.S. (Biviers, Grenoble, France). The deformable mirror controls both the 
monochromatic aberrations and focus adjustment, and the mouse is never moved, once it is 
positioned in the instrument. A resonant scanner (Electro-Optical Products Corp, Glendale, 
New York USA) line-scanned the retina horizontally at 15 kHz, and a slow galvometric 
scanner (GSI Group Corp, Massachusetts, USA) scanned the vertical direction at 25.5 Hz, 
forming a rectangular imaging raster. The wavefront sensor consisted of a lenslet array 
(Adaptive Optics Associates, Cambridge, Massachusetts, USA) with 7.8 mm focal length and 
203 μm lenslet pitch, and a Rolera XR camera from QImaging (Surrey, British Columbia, 
Canada). 
Light from the retina was split by a dichroic mirror into a reflectance channel and a 
fluorescence channel, before detection using photomultiplier tubes (PMT) H7422-40 and −50  
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Fig. 1. Schematic of the mouse eye fluorescence AOSLO. LD: fiber coupled laser diode. SLD: 
fiber coupled Super Luminescent Diode. PMT: photomultiplier tube. SHWS: Shack-Hartmann 
wavefront sensor. F: band pass filter. 90/10: 90/10 beam splitter. HS: horizontal scanner. VS: 
vertical scanner. M1-9: Concave spherical mirrors. 
from Hamamatsu Corporation (Hamamatsu, Shizuoka-Ken, Japan). The light reaching the 
PMTs was filtered spectrally by band-pass interferometric filters and spatially by confocal 
pinholes attached to the front of the PMTs. The confocal pinholes, used on the imaging 
channel, were between 1 and 3.9 Airy disks in diameter. The PMT output current was 
amplified and converted to voltage using transimpedance amplifiers (Femto, Berlin, 
Germany), inverted with in-house electronics, and digitized using a Matrox Odyssey eA 
framegrabber (Matrox International Corporation, Quebec, Canada). 
The first order optical design follows basic design guidelines for a similar instrument built 
for the human eye [21]. The deformable mirror is placed at the pupil conjugate closest to the 
eye, to minimize the area used on the optics. The other pupil plane elements are ordered to 
achieve a gradual change of magnification. Because of the large magnification factor between 
the deformable mirror plane and the pupil of the eye (approximately 7:1), an additional afocal 
telescope was added to gradually demagnify the pupil. In order to reduce the astigmatism due 
to using the spherical mirrors off-axis, spherical mirrors with long focal lengths (ranging from 
375 mm to 1000 mm) were selected. 
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~31-34 µm on the retina [28], which is an order of magnitude smaller than in the human eye. 
Therefore, the AOSLO used in for this work was designed to use a small 3° FOV (field of 
view) with diffraction limited performance, which can be continuously increased up to 10° by 
changing the scanning angles on both scanners for finding areas of interest. To accommodate 
a large FOV using all reflective parts, the system performance was heavily driven by the large 
angle of incidence needed on the spherical mirror closest to the eye, and an achromatic lens 
had to be used as the last optical element with power to achieve diffraction-limited 
performance. 
After the spherical mirrors were chosen, the only degrees of freedom left were the folding 
angles or angles of incidence on the spherical mirrors. The optical setup was folded in a non-
planar configuration to simultaneously minimize the monochromatic aberrations in retinal and 
pupil planes [21,31]. The optical layout was designed using CodeV (Optical Research 
Associates, Pasadena, California, USA) and Zemax (Zemax Development Corporation, 
Bellevue, Washington, USA). The angles of incidence on the off-axis spherical mirrors were 
optimized on both the x and y dimensions, under constraints for ray clearance and mechanical 
mount clearance. The combined optical performance (RMS wavefront error) was optimized 
on the retinal plane for 9 points uniformly distributed in the scanning field and for three 
different vergences (−30 D, 0 D, 30 D). 
The final system design had diffraction-limited performance for a vergence range of 60 D 
over a 3° × 3° FOV for high resolution AO imaging. The theoretical system optical 
performance is shown in Fig. 2 for the shortest wavelength reflected by the spherical mirror 
coating (450 nm). Note that all spot diagrams were calculated on the focal plane of the mouse 
eye, assuming a perfect mouse eye and a flat deformable mirror correction. The residual 
wavefront RMS at 450 nm  was low er than λ/20 for all vergences. Because of the mostly 
reflective nature of the setup, the system performed better for longer wavelengths. 
The pupil plane performance was characterized as the image quality for pupil plane re-
imaging. This was evaluated along the optical axis over the 3° × 3° scanning FOV, for a 
wavelength of 450 nm, using the same method as described previously [21]. Figure 3 shows 
spot diagrams on the 4 pupil planes. 
When the optical scanners move to form the imaging raster, if the aberrations are well 
corrected, the chief ray pivots around a stationary point in the center of the pupil planes. If this 
is not the case, then the chief ray moves or “wanders” in the pupil plane. This motion blurs the 
aberrations seen by the SHWS, thus degrading the AO correction. Therefore, we describe the 
optical performance of the AOSLO in the pupil planes in terms of both the wavefront RMS 
and the maximum displacement of the chief ray. This beam wander for a 3° × 3° FOV and  
 
Fig. 2. Spot diagrams for 27 configurations evaluated at the retinal plane, over a 3° × 3° FOV 
for a vergence range of 60 D in the mouse AOSLO optical design. Configurations are grouped 
by vergences, and all configurations are diffraction limited for 450 nm of wavelength. The 
radius of Airy disk (Black circle) is 0.59 µm. 
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Fig. 3. Spot diagrams for the 4 pupil planes of the mouse AOSLO at 450 nm over a 3° × 3° 
FOV, for an on-axis point object at the SHWS pupil plane. Different scanning configurations 
are coded by color. Black circle represents the Airy disk. 
60 D of vergence range was ~1% of the pupil diameter (2.0 mm) for a wavelength of 450 nm, 
and ~4% for a combination of 450 nm, 650 nm and 850 nm light. 
For an 8° × 8° FOV, the system is diffraction-limited over a vergence range of 40 D. The 
wavefront RMS for wavelength of 450 nm is better than are λ/14 for a −22 D to +18 D 
vergence range. Beam wander at the eye’s pupil is ~3% of the pupil diameter for 450 nm 
light, and ~7% for a combination of wavelengths from 450 nm to 850 nm. 
2.2. Adaptive optics 
Wave aberrations were measured and corrected at 15 Hz frame rate. Before any source focus 
compensation and AO correction, the SHWS spots often appear blurry, as shown in Fig. 4(a). 
When the AO loop is closed, the spots become brighter and sharper, as shown in Fig. 4(b). It 
typically takes 0.2 seconds (i.e. three iterations) to reach a stable AO correction, with a 
residual wavefront RMS error at or below 0.05 µm. We always focused the beacon on the 
photoreceptors to maximize the quality of the SHWS spots. However, we often want to image 
other planes with light passing through the same deformable mirror. In that case, the change in 
deformable mirror focus required to image a different layer must be compensated in the 
wavefront sensing beacon by moving the source fiber tip, so that the beacon stays focused on 
the photoreceptors. The beacon was refocused by either maximizing subjective sharpness of 
the SHWS spots, or using a previous calibration done for similar layers. 
 
Fig. 4. Typical SHWS spot patterns before the spots are focused on the wavefront sensing 
source or AO correction (a), and after AO correction (b). The spots are brighter and sharper 
after AO correction. These SHWS spot patterns are taken at a scanning field of 5° × 5°. Each 
wavefront sensor spot is sampled by 16 × 16 pixels on the CCD camera. The width of both 
images is approximately 465 pixels. 
2.3. Animals, and preparations for in vivo imaging 
Adult wild type mice (C57BL/6J) or transgenic mice (B6.Thy1-YFPH) were imaged [32]. All 
mice were from 3 to 10 months old and weighed between 20 and 30 grams. Mice were housed 
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to the Association for Research in Vision and Ophthalmology Statement for the Use of 
Animals in  Ophthalmic and Vision Research and to the guidelines of the University 
Committee on Animal Resources at the University of Rochester. 
Mice were anesthetized with either Ketamine/Xylazine cocktail injections (100mg/kg and 
10mg/kg) only or combined with isofluorane gas (1-2%) and placed on a heating pad prior to 
in vivo imaging. Pupils were dilated with one drop of 2.5% phenylephrine (Neo-Synephrine) 
and one drop of 0.5% tropicamide. A 0 to +10 D rigid contact lens (Unicon Corporation, 
Osaka, Japan) with a base curve between 1.55 to 1.70 mm was placed on the eye to maintain 
corneal hydration during in vivo imaging. Mice were stabilized on a bitebar stage with two 
rotational degrees of freedom as described previously (Bioptigen, Research Triangle Park, 
North Carolina, USA) [15]. 
2.4. Power levels, image acquisition and analysis 
The maximum permissible light exposure (MPE) for the mouse eye was calculated assuming 
that the mouse retina possessed the same susceptibility to light damage as the human retina. 
These calculations included a scaling factor that incorporated the differences in the spot size 
and retinal illuminance at the mouse retina due to its higher NA. For reflectance imaging, 40 
µW and 250 µW were used for the 843 nm laser diode and 789 nm SLD, respectively. Even 
though the system was to be diffraction-limited for a 3° × 3° high resolution FOV (Figs. 2 and 
3), during imaging it was often found that this FOV was too small to cover areas of interest. In 
reality we often image with a larger FOV (e.g. 5° × 7°), at the cost of slightly larger system 
aberrations and the FOV is probably outside of the eye’s isoplanatic size. The combined 
powers were less than the MPE for a 20-minute exposure time for a 5° × 7° FOV according to 
the ANSI guide for the safe use of lasers [33,34]. For fluorescence imaging, cells were imaged 
using 300 µW of 514 nm laser power measured at the pupil of the eye. This power level, 
combined with that from the other two sources, is 1.8 times the ANSI MPE for imaging the 5° 
× 7° FOV for 5 minutes [33,34]. 
To convert from visual angle to dimensions on the retina, a paraxial model for 100 days 
old C57BL/6 mice was used [28]. It was calculated that every degree of visual angle 
corresponds to approximately 34 µm for this model. 
To image different layers of the retina using the two channels simultaneously (reflectance 
and fluorescence), source and detector focuses for both channels were adjusted separately 
prior to imaging. Sinusoidal frame distortion from the motion of the resonant scanner was 
compensated by estimating the distortion from imaging a grating target placed in a model eye, 
and resampling the images using equally spaced pixels. Single in vivo fluorescence frames 
typically possessed very low signal to noise ratio (SNR). Therefore, multiple fluorescence 
frames were averaged to obtain an image with higher SNR. To account for eye movements 
between different frames, images were registered using the shifts calculated from 
simultaneously acquired reflectance images [35]. 
2.5.  Labeling of ganglion cells, in vivo  ganglion cell classification, and ex vivo  confocal 
imaging 
Ganglion cells were fluorescently labeled with yellow fluorescence protein (YFP) by one of 
two methods. The first was a transgenic mouse line that expresses YFP in a small subset of 
retinal ganglion cells (B6.Thy1-YFPH). In the second method, retinal ganglion cells in an 
adult C57BL/6J mouse were sparsely labeled with YFP via transduction from retrograde viral 
vector (Equine infectious anemia virus carrying YFP gene; Vector courtesy of Drs. Edward 
M. Callaway and Ali H. Cetin at the Salk Institute of Biological Studies, California, USA). 
Image stacks were taken from the somas and dendrites of the sparsely labeled ganglion 
cells for classification. Typical image stacks contained 10 slices (with 750 frames averaged 
for each focus), approximately 6 µm apart in depth and were collected in 5 minutes. 
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multiple in vivo imaging sessions. Retinas were isolated and placed as wholemounts on slides 
with coverslips and covered in mounting medium (Vectashield; Vector Laboratories, 
Burlingame, California, USA). To visualize boundaries of inner plexiform layer (IPL), cell 
nuclei in both the ganglion cell layer and the inner nuclear layer were labeled with DAPI 
overnight. Wholemount images were acquired using a confocal microscope (Olympus 
FV1000; Olympus, Center Valley, Philadelphia, USA). Image stacks were taken at the same 
locations as the in vivo images using a 40X (1.3 NA) oil immersion microscope objective, and 
maximum intensity projection images were generated for each stack. 
3. Results and discussion 
3.1. Imaging of nerve fiber bundles 
The innermost surface of the retina contains the nerve fiber layer (NFL) and blood vessels. As 
shown in Figs. 5 and 6, individual nerve fiber bundles, blood vessels and capillaries were  
 
Fig. 5. In vivo reflectance image of the NFL close to the optic disk in the mouse eye. This 
image was an average of 100 frames. Confocal pinhole diameter was 2.1 Airy disks. Arrows: 
examples of nerve fiber bundles. Arrowhead: example of capillaries. Image was contrast 
stretched for display purposes. Scale bar: 20 µm. 
 
Fig. 6. In vivo reflectance image montage of the NFL in the mouse eye, showing a large blood 
vessel in the center, capillaries, and nerve fiber bundles. This location was over 15 degrees 
away from the optic disk. Size of this image was 553 µm × 230 µm, or 16.3° × 6.8°. Each 
individual image was an average of 50 frames. Confocal pinhole diameter was 2.1 Airy disks. 
Scale bar: 20 µm. Image was contrast stretched for display purposes only. 
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retinal location imaged was farther away from the optic disk. Microscopic structures shown as 
bright white dots could be seen on the nerve fiber bundles, similar to what Dubra et al. 
recently observed in human subjects and postulated that they may be ganglion cell axonal 
varicosities (unpublished observations) [36]. In between the nerve fiber bundles, some hints of 
dark “holes” could be seen, with diameters on the order of 5-20 µm. We speculate that these 
dark “holes” may be ganglion cells. 
3.2. Imaging of blood vessels 
The supplemental video (Media 1) shows an image stack 135 µm thick, starting at the NFL 
and moving towards the photoreceptors. Other than the layer of blood vessels and capillaries 
seen in the NFL, at least two more layers of blood vessels/capillaries were visualized in the 
mouse retina, corresponding to the three layers of microvessels found in histology (in the 
ganglion cell layer, inner plexiform layer (IPL), and outer plexiform layer) [37,38]. In this 
video, the focus depths of the two layers were 68 and 116 µm sclerad from the best focus for 
the NFL, respectively. Another example of the two capillary layers is shown as averaged 
images in Figs. 7(b) and (a). The contrast of the capillaries can be enhanced by computing the 
standard deviation of each pixel throughout the series of registered frames [39,40]. Figure 7(c) 
shows the standard deviation image corresponding to Fig. 7(a). There were unknown  
 
Fig. 7. In vivo reflectance capillary images in the mouse retina. All images are taken at the 
same retinal location. (a), (b), (d) Capillary images at different depths. Each image is a 
registered average of 50 individual frames. (c) Standard deviation/motion contrast image 
corresponding to the depth of image (a). Arrows and arrowhead: dark regions and microscopic 
bright point structures within the intermediate capillary layer. Confocal pinhole diameter was 
2.1 Airy disks. All images were contrast stretched identically for display purposes. Scale bar: 
20 µm. 
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holes. This can be seen especially in Fig. 7(d), at an axial focus ~45 µm deeper than the NFL, 
which was probably in the IPL. The bright spots (arrowhead) may be related to fine processes 
of ganglion cells and amacrine cells in the inner nuclear layer. There are subtle dark regions 
between the bright spots (arrows) with spacing between 6 µm to 10 µm, consistent with ex 
vivo estimates of Müller cell spacing at 8.5 µm [41], however positive identification of these 
structures has yet to be established. 
With the axial resolution afforded by the mouse eye’s high NA, capillary layers separated 
by 30 µm can be clearly resolved with no visible cross talk between Figs. 7(a) and (b). At the 
best focuses for capillaries, motion contrast enhancement [39,40] did not increase the image 
contrast significantly. Motion contrast can help to increase blood vessel contrast for focus 
positions such as Fig. 7(d), and can also highlight functional changes such as hemostasis 
events [42]. Different analyses can be done using the high quality in vivo imaging videos 
(Media 1), including blood vessel diameter, blood flow velocity/blood cells tracking, and 3 
dimensional reconstructions of the inner retina. Methods developed for monitoring both the 
morphology and function of capillaries in human and primates can all potentially be used on 
the mouse [42–45]. 
3.3. Imaging of photoreceptors 
Due to the small spacing of the mouse photoreceptors, it has not been possible in previous 
studies to image the complete mosaic in the living eye. With the AOSLO, the photoreceptor 
mosaic in a live mouse can be imaged non-invasively, as shown in Fig. 8(a). The 
photoreceptor mosaic was imaged in reflectance, possibly showing both rods and cones. 
Mouse photoreceptors spacing shows very small variation with retinal eccentricity, less than 
40% for cones, and less than 20% for rods [41]. Ex vivo data assuming triangular packing 
indicates average nearest neighbor distances of 1.63 µm for rods and 1.60 µm for rods and 
cones combined [41]. The concentration of energy in the mosaic spectrum in Fig. 8(b) had a 
radius corresponding to that predicted from histological observations (1.60 µm), confirming 
that the observed pattern represents the structure of photoreceptors. The partial circle in Fig. 
8(b) indicates the spatial frequency calculated using a 1.60 µm nearest neighbor distance, in 
agreement with the spectrum of the in vivo image. 
 
Fig. 8. (a) Photoreceptors imaged in reflectance in the mouse eye. This image is an average of 
120 frames. Scale bar: 10 µm. (b) Fourier spectrum of the photoreceptor image in (a), showing 
a concentration of energy at a fixed radius from the origin. The partial circle indicates the 
spatial frequency calculated using a 1.60 µm nearest neighbor distance. Confocal pinhole 
diameter was 2.1 Airy disks. Image (a) was contrast stretched for display purposes. 
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In vivo fluorescence imaging of ganglion cells has been previously demonstrated, allowing the 
detection of cell drop out [9,46,47]. More recently, axons and dendrites have been resolved in 
retinas with sparsely labeled ganglion cells in vivo [12,14]. Using the same transgenic mouse 
line, we were able to image individual ganglion cells and processes with much finer resolution 
than previous studies. The increased axial resolution afforded by AO has allowed us to 
optically section the cell in vivo. 
Individual ganglion cells expressing YFP were imaged with the AOSLO, using 514 nm as 
excitation wavelength. Fluorescence was collected using an interference filter with 534 nm 
central wavelength and 38 nm bandwidth. After image registration and averaging, the fine 
details of retinal ganglion cells were resolved. Figures 9(a)-(c) show a ganglion cell imaged at 
three different focuses, at focus steps of 11.6 μm. At the innermost focus shown in (a), apart 
from a cell body with its nucleus, two axons were in sharp focus. At an intermediate focus 
shown in (b), the axons were out of focus and the proximal dendrites of the cell started to 
come into focus. Finally at the outermost focus shown in (c), the axons were almost 
completely out of focus and the dendritic field was sharply in focus. Figure 9(d) shows a 
maximum intensity projection image generated from (a)-(c) and another two intermediate 
focus images. 
Using large blood vessels as landmarks, we were able to follow the same ganglion cells 
over time. Figure 10 shows another ganglion cell imaged on two different sessions one month 
apart. Both images were taken using the same power levels and confocal pinhole sizes, and 
the same fine processes can be resolved over time. The first image was taken with a combined 
power level at 1.8 times the ANSI MPE (scaled down for the mouse eye as described in the  
 
Fig. 9. In vivo fluoresence images of a ganglion cell expressing YFP. (a-c) Individual images 
from three of the focuses, at focus steps of 11.6 μm. Each image at an individual focus step was 
a registered image average of 500 frames. (d) Maximum intensity projection image generated 
from 5 separate in vivo images taken at focus steps of 5.8 μm. Confocal pinhole diameter was 
3.9 Airy disks. All images were contrast stretched identically to preserve their relative 
brightness. Scale bar: 20 µm. 
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Fig. 10. In vivo imaging of the same fluorescent ganglion cells at times separated by one 
month. Image shown in (a) and (b) are taken one month apart. Both images are maximum 
intensity projection images generated from 10 separate in vivo images at individual focuses. 
Each image at an individual focus is a registered average of 750 frames. Confocal pinhole 
diameter was 1.9 Airy disks. Images were contrast stretched identically for display purposes. 
Scale bar: 20 µm. 
Methods section), yet no visible damage could be identified in image stacks spanning the 
inner retina and the photoreceptor layer in the same location after one month. 
3.5. Characterization of in vivo transverse resolution 
To estimate the in vivo resolution of the imaging system, the transverse cross section across 
isolated dendrites was measured to be the upper limit of the transverse line spread function 
(LSF). Note that this resolution characterization was done for the fluorescence imaging 
channel, and was a conservative estimate. Given that focus adjustment for both the source and 
confocal pinhole is more difficult for fluorescence imaging than reflectance imaging, 
resolution for the reflectance channel may be better than what is shown here. Figure 11(a) 
shows a maximum projection image taken from a focus stack of 7 slices spaced 5.8 μm. The 
full width half maximum (FWHM) of the transverse cross sections were measured on 9 
different locations at their best focuses on the ganglion cell dendritic structure (Fig. 11(b) is 
shown as an example of a dendrite at its best focus). The measured FWHM of a dendrite cross 
s e c t i o n  w a s  0 . 7 9  μ m  ±  0 . 0 3  μ m  ( m e a n  ±  S T D )  f o r  t h e  9  l o c a t i o n s .  I n  c o m p a r i s o n ,  t h e  
theoretical FWHM of the LSF is 0.54 μm (calculated for NA of 0.49, wavelength of 534 nm, 
and confocal pinhole disk diameter of 1.2 Airy disks). The measured average in vivo dendrite 
cross section was 45% wider than the theoretical LSF. The measurement profile for a typical 
dendrite cross section labeled by a yellow line in Fig. 11(b) is plotted as an example. In Fig. 
11(d), circle data points are the in vivo measurement, and solid gray line shows the theoretical 
LSF. 
This in vivo dendrite cross section profile represents a convolution of the dendrite profile 
and the system LSF. In the mouse eye, the diameter of ganglion cell dendrites ranges from 0.7 
μm to 1.75 μm as estimated form histology [48]. A rough estimate assuming a dendrite width 
of 0.70 μm convolved with the theoretical LSF of the system yields a profile (dashed line in 
Fig. 11(d)) with a FWHM of 0.8 μm, which corresponds very well to the measured in vivo 
FWHM of 0.79 μm ± 0.03 μm. Therefore if the true dendrite diameter is about 0.7 μm at this 
location, the in vivo transverse resolution is near diffraction-limited. 
The measured in vivo FWHM of 0.79 μm ± 0.03 μm is a conservative estimate of the real 
system LSF. It would be preferable to measure both the length and diameter of the same 
dendrite from histology, to confirm that our in vivo image scaling from degrees to µm was 
correct and the actual in vivo LSF was near diffraction-limited. Unfortunately histology data 
for this particular location was not available. However, direct comparison of in vivo images to 
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transverse image scaling estimated from paraxial eye model [28] matched very well with ex 
vivo images. 
3.6. Characterization of in vivo axial resolution 
To estimate the in vivo  axial resolution of the imaging system, the axial cross section 
generated by point objects was measured to be the axial point spread function (PSF). These 
point objects presumably correspond to local concentrations of fluorescence in some ganglion 
cells. The same focus stack used for transverse resolution characterization was used for this 
analysis. The theoretical FWHM of the axial PSF is 4.6 μm , and in vivo point structures 
measured in this stack were all sub-resolution compared to the theoretical axial PSF. 
The FWHM of the axial cross sections were measured on 6 different locations of the 
ganglion cell dendritic structure shown in Fig. 11(a). Intensity was measured at the same 
locations of the image for all focus depths within each focus stack. The measured FWHM of 
the axial cross section of point objects was 10.8 μm ± 0.7 μm (average ± standard deviation). 
Axial profile measurement on a typical point object in Fig. 11(c) (arrow) is plotted as an 
example. In Fig. 11(e), circle data points are the in vivo measurement, and solid gray line 
shows the theoretical PSF. The measured FWHM of the axial cross section of point objects is 
2.4 times larger than the theoretical axial PSF FWHM. 
 
Fig. 11. Characterization of the in vivo  resolution using an image stack of a fluorescent 
ganglion cell. (a) Maximum projection image for a focus stack. (b) One individual focus from 
the focus stack. Transverse cross section on a typical dendrite labeled in yellow is plotted as an 
example in (d). (c) An individual focus image 11.6 μm shallower than the focus in (b). Arrow 
indicates measurement position for a typical axial cross section shown in (e). (d) and (e) are the 
characterization of the in vivo transverse and axial resolution, respectively. Circle data points: 
in vivo measurement. Solid black line: spline fit to in vivo measurement data. Solid gray line: 
theoretical diffraction-limited axial PSF. Scale bar: 20 µm. 
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When imaging objects that are sparsely distributed axially, the axial position of an object or 
the peak of its axial intensity profile can be localized more accurately than the axial 
resolution. An axial image stack was equally divided into four image stack segments to 
characterize the in vivo axial positioning accuracy of the mouse AOSLO. Each of the four 
image stack segments was processed identically. The relative axial positions of 10 different 
point objects was measured in each of the segments, and the standard deviation of the axial 
position or the positioning accuracy was 0.36 μm, 30 times smaller than the measured axial 
FWHM of 10.8 μm. This 30-fold difference is consistent with what was previously reported 
for an AOSLO developed for the primate eye, which had an axial resolution of 115 μm and a 
positional accuracy of 4 μm [19]. 
This fine in vivo  axial  positional  accuracy  of  0.36  μm  has  a  number  of  important 
applications. For example, the stratification of the processes of ganglion cells can be 
potentially localized to the positional accuracy, enabling classification of ganglion cells in 
vivo. 
3.8. Ganglion cell morphological classification, and direct comparison of in vivo to ex vivo 
images 
Ganglion cell morphological classification has been studied extensively using ex vivo 
preparations, and over 14 sub-types have been identified on this basis alone [48–51]. 
Parameters used for anatomical classification include dendritic pattern (e.g., density of 
branching), depth of dendrite stratification in IPL, extent of dendritic field, and soma size. 
While the extent of dendritic field and soma size can be measured using conventional in vivo 
imaging methods, only the AOSLO reported in the current paper can measure the dendritic 
stratification, and reveal the fine details of dendritic patterning. Being able to classify 
ganglion cells in vivo would create a platform for combining morphological and functional 
imaging of different cell types in an intact model to study retinal circuitry. 
Because we currently don’t have an in vivo preparation that labels the boundaries of the 
IPL, we approximated the start of the IPL as the axial position of the proximal dendrites. The  
 
Fig. 12. Direct comparison of in vivo and ex vivo mouse monostratified ganglion cell. In vivo 
image dimensions (degree to µm conversion calculated using paraxial eye model [28]) matched 
very well with ex vivo image dimensions. (a) Ex vivo histological image acquired using a 40x 
oil immersion confocal microscope with a 1.3 NA objective. (b) In vivo image in a mouse 
retina taken with AO correction over a 0.49 NA. The in vivo image was a maximum intensity 
projection image generated from 11 in vivo images taken at different depths. Ex vivo image was 
a maximum intensity projection image generated from an image stack of 51 images. Confocal 
pinhole size was 1 Airy disk for ex vivo, and 1.9 Airy disks for in vivo imaging. Scale bar: 20 
μm. 
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Fig. 13. Direct comparison of in vivo and ex vivo mouse bistratified ganglion cells. All imaging 
parameters used were the same as that used for the cell imaged in Fig. 12. 
total depth of the mouse eye IPL was approximated to be 35 µm, as measured from ex vivo 
data published by Haverkamp and Wassle [52]. Parameters measured in this work for each 
cell are: depth of dendritic stratification, dendritic field size and soma size. To estimate 
dendritic field size for cells with large dendritic field, low-resolution images with large 7° × 
9.3° (~230 µm × 300 µm) FOV were taken. 
Both monostratified ganglion cells and bistratified cells were identified through in vivo 
imaging. Ganglion cell structures and depth of dendritic stratification measured in vivo were 
directly compared to that measured ex vivo in the same retinal locations. Figure 12 shows a 
monostratified ganglion cell under comparison. Despite that in vivo imaging NA was much 
smaller than that of ex vivo confocal imaging (0.49 vs. 1.3), almost all the fine details of the 
ganglion cell dendrites and axon seen ex vivo were also resolved in vivo. This cell stratified 
into the ON sublaminae [48,49]. Despite that different methods were used to identify the  
 
Fig. 14. In vivo imaging of six more monostratified ganglion cells. Shadows from large blood 
vessels can be seen in images of cell 2, 4 and 6. Cells 5 and 6 are taken from transgenic mice 
with ganglion cells expressing YFP, and all other cells are labeled with retrograde viral vector. 
Images are contrast stretched for display purposes. Scale bar: 20 μm. 
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stratification within the IPL showed good agreement. The average depth of dendrite 
stratification measured in vivo was 29% of the estimated total IPL thickness, matching very 
well with ex vivo measurement of 28%. Figure 13 shows a bistratified ganglion cell imaged 
both ex vivo and in vivo. Two layers of dendrites separated by ~35% of the IPL or 12 µm 
could be resolved. The average depth of the dendrite stratification was 49% and 84% as 
measured in vivo, and was 45% and 80% as measured ex vivo. 
Figure 14 shows six more monostratified cells imaged in vivo, and Fig. 15 shows three 
more bistratified cell examples. Tables 2 and 3  summarize their depth of dendritic 
stratification measured in vivo, and the proposed matching ganglion cell types in the literature. 
As was described previously, apart from dendritic stratification, dendritic field size and soma 
size were also measured from in vivo images and were used to match cell types (not shown in 
tables). 
Table 2. In vivo classification of a few monostratified ganglion cells 
  
In vivo  Matching cell types and their dendrite stratification 
Dendritic stratification  Coombs et al. [48]  Sun et al. [49]  Kong et al. [51] 
Cell 1  65%  M1  RGB2, 67% ± 16%    
Cell 2  44%  M2    1, 55% 
Cell 3  88%     RGB4, 66% ± 12%    
Cell 4  72%  M3     3, 73% 
Cell 5  47%  M7 
RGA2 inner, 29% ± 7%  5, 26%  Cell 6  30% 
M8 
Cell from Fig. 12  28% 
 
Fig. 15. In vivo imaging of three more bistratified ganglion cells. The left column shows the 
maximum projection image of the cell; middle and right columns shows the dendrite 
stratifications at 2 different focuses. All images are contrast stretched for display purposes. 
Scale bar: 20 μm. 
Maximum projection image              OFF stratification               ON stratification 
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In vivo  Matching cell types 
Dendritic stratification  Coombs et al. [48]  Sun et al. [49] 
Cell a  49% and 72%  M11  RG D1, 44% ± 8% and 71% ± 8% 
Cell b  42% and 78%  M13  RGD2, 39% ± 10% and 71% ± 12% 
Cell c  56% and 96% 
M14   
Cell from Fig. 13  49% and 84% 
4. Conclusions and future directions 
In vivo imaging of the mouse eye can provide higher transverse and axial resolution than of 
the human eye, despite challenges encountered in previous studies [23,24]. We have 
constructed a confocal scanning AO instrument with a wavefront sensor operating on back-
scattered light, providing a fast and effective correction of mouse eye aberrations. The 
imaging part of the instrument was custom designed for the mouse eye to provide diffraction-
limited optical performance over a 60 D vergence range, and low beam wander on the eye’s 
pupil plane. After AO correction, the photoreceptor mosaic, nerve fiber bundles, fine 
capillaries and blood flow were visualized in vivo non-invasively in reflectance. Ganglion cell 
bodies, dendrites and axons were clearly resolved in registered in vivo fluorescent images. 
Compared to a previous system we modified for AO imaging in the rat eye [25], this 
system was purposely built for the mouse eye, utilizing the eye’s full NA and delivering 
images with higher resolution and contrast. Imaging resolution characterized directly from in 
vivo images was sub-micron laterally, and ~10 µm axially. 
We report the first in vivo images of the photoreceptor mosaic in mice. The ability to 
identify ganglion cell types based on the plane of stratification indicates the unprecedented in 
vivo axial resolution. 
Together with current powerful molecular techniques that exist for engineering the mouse, 
this high resolution in vivo method opens new doors for many investigations and experiments. 
AO imaging of mouse models has potential for investigating retinal development, disease 
mechanisms and evaluating the efficacy of drug therapies. For example, capillary morphology 
and blood flow can be studied longitudinally for mouse models of vasculature diseases such 
as diabetic retinopathy. For mouse models of glaucoma, ganglion cells and their processes as 
well as microscopic structures in the nerve fiber layer can be monitored during disease 
progression or treatment. With the fine in vivo axial positional accuracy reported here (0.36 
µm), the axial movement of small isolated features or processes could potentially be finely 
tracked for their response to light or over the visual cycle, or a longer time scale for retinal 
development or disease progression. 
While we have concentrated on reflective structures and fluorescently labeled ganglion 
cells in this study, the observed resolution indicates that it is possible to use the fAOSLO to 
image a variety of other retinal structures. These include individual pericytes, Müller glial 
cells, bipolar cells and amacrine cells that are fluorescently labeled in transgenic mice [53,54], 
or using cell-specific adeno-associated virus (AAV) and lentiviral vectors [55–58]. Also 
included are autofluorescent retinal pigment epithelium cells that may be resolved without 
using extrinsic fluorophores [59]. 
Other than imaging morphology, the mouse AOSLO may also provide measures of retinal 
function at a cellular and subcellular scale. Combining AOSLO imaging with recent 
advancement in optogenetics, it will be possible to study and manipulate retina circuitry in an 
intact retina. Using genetically encoded calcium indicators, we have started to record the light 
response of ensembles of ganglion cells in the living mouse eye [60]. We have also started 
probing the function of pericytes in regulating capillary blood flow [61]. Furthermore, this 
instrument can be used to image and probe other retinal cells that are presynaptic to ganglion 
cells, such as bipolar cells and amacrine cells. In the future, we could capitalize on transgenic 
mouse lines with sub-type specific markers for ganglion cells or other retinal cell types 
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us to characterize retinal circuitry by optically monitoring the electrical activity of large 
numbers of interconnected neurons simultaneously. 
The current system operates as a confocal AOSLO, and needs a confocal pinhole to 
achieve axial sectioning. Two-photon imaging is a method to achieve intrinsic axial resolution 
by preferentially exciting fluorophores near the focal volume, thus reducing photobleaching 
[64]. Adaptive optics two-photon imaging has been demonstrated for imaging photoreceptors 
in the living primate eye [65], and we expect an increase in two-photon signal intensity in a 
mouse eye with larger NA. Modifying a confocal mouse AOSLO to accommodate two-photon 
imaging involves the addition of an ultrafast pulsed laser, and a channel for direct detection of 
two-photon fluorescence by-passing the de-scanning optics used for confocal detection [66]. 
For functional imaging using extrinsic fluorophores, such as optical recording of ganglion 
cells, it allows imaging with an IR wavelength outside of the retina’s sensitivity range, 
avoiding intense stimulation caused by single-photon fluorescence imaging. Two-photon 
imaging also permits excitation of multiple endogenous fluorophores, such as NADH, that are 
functional markers of cell metabolism. All kinds of transparent retinal structures contain two-
photon excitable intrinsic fluorophores, and can be imaged with high contrast on a two-photon 
microscope ex vivo. If enough signal intensity can be collected in the mouse eye using AO 
two-photon imaging, potentially both the morphology and function of any retinal cell types 
may be monitored in vivo without the use of exogenous fluorophores. 
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